The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126280601 12628060 1 I 20160801 20160808 20160808 EXP CN-ROCHE-1806210 ROCHE YUN-HONG T, ZOU W, XIAO W, ZENG L, YUAN X, BAI L, LU T, TIAN Y, AND HAN F OLIGOMETASTASES IN AJCC STAGE IVC NASOPHARYNGEAL CARCINOMA: A SUBSET WITH BETTER. HEAD AND NECK 2016 AUG 01;38 (8):1152-1157. 0.00 Y 0.00000 20160808 MD CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126280601 12628060 1 PS CAPECITABINE. CAPECITABINE 1 Oral ON DAYS 1-14 U 20896 1000 MG/M**2 TABLET BID
126280601 12628060 2 SS CISPLATIN. CISPLATIN 1 Intravenous (not otherwise specified) 25-30 MG/M2 I.V. ON DAYS 1-3 U 0
126280601 12628060 3 SS PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) DAY 1 U 0 175 MG/M**2
126280601 12628060 4 SS 5-FLUOROURACIL FLUOROURACIL 1 Intravenous (not otherwise specified) DAY 1 - 5 U 0 500 MG/M**2

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126280601 12628060 1 Nasopharyngeal cancer
126280601 12628060 2 Nasopharyngeal cancer
126280601 12628060 3 Nasopharyngeal cancer
126280601 12628060 4 Nasopharyngeal cancer

Outcome of event

Event ID CASEID OUTC COD
126280601 12628060 OT
126280601 12628060 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
126280601 12628060 Hepatic failure
126280601 12628060 Infection
126280601 12628060 Leukopenia
126280601 12628060 Mucosal inflammation
126280601 12628060 Skin reaction

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found